The Impact of Dosing Interval in a Novel Tandem  Oral Dosing Strategy: Enhancing the Exposure of Low  Solubility Drug Candidates in a Preclinical Setting

<table>Compound 1 50 mg/Kg X3 tandem dose (1, 1.5, and 2.5 hrs interval) exposure comparison.</table>

Journal of Drug Delivery

fig4

Figure 4

Figure 4: The Impact of Dosing Interval in a Novel Tandem  Oral Dosing Strategy: Enhancing the Exposure of Low  Solubility Drug Candidates in a Preclinical Setting 

Figure 4 | The Impact of Dosing Interval in a Novel Tandem  Oral Dosing Strategy: Enhancing the Exposure of Low  Solubility Drug Candidates in a Preclinical Setting 